Metastatic ovarian cancer represents the most advanced form of the disease, where cancer cells have traveled from the ovaries to distant areas of the body. Understanding treatment approaches, both established and experimental, can help patients and their families navigate this challenging phase with greater clarity and hope.

Understanding Treatment Goals When Cancer Has Spread

When ovarian cancer reaches a metastatic stage, the approach to treatment shifts in important ways. At this point, cancer has spread beyond its original location in the ovaries to more distant parts of the body, such as the liver, lungs, or the lining around the lungs. This is classified as Stage IV ovarian cancer, the most advanced stage of the disease.^[1] Treatment at this stage focuses on several key goals: controlling the growth and spread of cancer cells, managing symptoms to maintain comfort, and improving overall quality of life for as long as possible.^[7]

The specific treatment plan depends heavily on where the cancer has spread, how much disease is present, what treatments have already been tried, and the patient’s overall health and fitness level. Medical professionals consider all these factors when recommending a path forward.^[7] Some patients with metastatic disease may still be candidates for aggressive treatment approaches, while others may benefit more from therapies aimed at symptom relief and maintaining the best possible quality of life.

It is important to understand that metastatic ovarian cancer differs from recurrent ovarian cancer. Metastasis refers to cancer that has spread to new locations, while recurrence means cancer has returned after treatment. Sometimes cancer cells survive initial treatment or remain too small to detect, then cluster and grow over time, leading to recurrence. If ovarian cancer has already metastasized at the time of treatment, the risk increases that some cancerous cells may be left behind, potentially leading to distant recurrence in another part of the body.^[4]

Modern treatment guidelines, developed by medical societies and cancer experts, provide a framework for managing metastatic ovarian cancer. These guidelines incorporate both standard therapies that have been used for years and newer approaches being tested in research studies called clinical trials. The landscape of treatment continues to evolve as researchers discover new ways to fight this disease and improve outcomes for patients.^[8]

Standard Treatment Approaches for Metastatic Ovarian Cancer

The foundation of treatment for metastatic ovarian cancer typically involves a combination of surgery and chemotherapy, which uses anti-cancer drugs to destroy cancer cells throughout the body. The specific approach depends on individual circumstances, but certain strategies have become standard practice based on years of clinical experience.^[9]

Surgical Intervention

Even when cancer has spread, surgery often plays an important role. The goal of surgery is to remove as much visible cancer as possible, a procedure called cytoreductive surgery or debulking surgery. During this operation, surgeons typically remove both ovaries, the fallopian tubes, and the uterus (including the cervix). They also check where cancer has spread in the pelvis and whether it has reached the lymph nodes.^[7]

For patients with Stage IV disease, the surgical approach must be individualized. Those with small-volume disease in the liver, abdominal wall, or chest may still be candidates for cytoreductive surgery if they are medically fit. The surgery may require extensive work, potentially including bowel resection, removal of peritoneal implants, liver resection, removal of the omentum (a fatty apron of tissue in the abdomen), and sometimes splenectomy.^[14] However, if the cancer has spread widely or the patient is not well enough for such extensive surgery, other options may be considered first.

Some patients receive chemotherapy before surgery to shrink the cancer, making it easier to remove. This approach is called neoadjuvant chemotherapy, followed by interval cytoreductive surgery and then additional chemotherapy afterward.^[7] This strategy can be particularly helpful for patients who would not initially be candidates for optimal tumor removal.

Chemotherapy Regimens

Chemotherapy forms a cornerstone of treatment for metastatic ovarian cancer. The most commonly used regimen combines two drugs: carboplatin and paclitaxel. Carboplatin is a platinum-based drug that damages the DNA inside cancer cells, preventing them from dividing and growing. Paclitaxel belongs to a class of drugs called taxanes, which interfere with the internal structure of cells needed for division.^[9]

The standard approach involves giving chemotherapy after surgery, known as adjuvant chemotherapy. Alternatively, as mentioned earlier, chemotherapy may be given before and after surgery. In some specialized centers, patients may receive hyperthermic intraperitoneal chemotherapy (HIPEC) during surgery, where heated chemotherapy is delivered directly into the abdominal cavity.^[7]

For cancer that has returned after previous treatment, doctors have several chemotherapy options. Some patients may receive carboplatin again if enough time has passed since their last treatment. Others might try different chemotherapy drugs to see if the cancer responds better to an alternative approach.^[13]

Chemotherapy comes with side effects that vary from person to person. Common short-term effects include muscle and joint aches, weakness in the legs, peripheral neuropathy (numbness and tingling in the fingers and toes), nausea, vomiting, fatigue, and loss of appetite. Bowel issues are particularly common because ovarian cancer often affects the intestines. Some patients experience diarrhea or constipation, and in more serious cases, bowel obstruction can occur.^[16]

Targeted Cancer Drugs

Beyond traditional chemotherapy, several targeted cancer drugs have become important tools in treating metastatic ovarian cancer. These medications work by attacking specific features of cancer cells or blocking processes that tumors need to grow and spread.

One important class of targeted drugs is PARP inhibitors, which block enzymes involved in DNA repair. When cancer cells cannot repair their DNA properly, they die. Three PARP inhibitors are approved for ovarian cancer: olaparib, niraparib, and rucaparib. These drugs are particularly effective in patients with BRCA gene mutations. Genetic testing helps determine if a patient has such mutations, making them eligible for PARP inhibitor maintenance therapy, typically given for about two years after chemotherapy to help keep the cancer in remission.^[11][13]

Bevacizumab is a monoclonal antibody, a type of protein engineered in the laboratory to attach to specific targets on cancer cells. Bevacizumab works by preventing the growth of new blood vessels that tumors need to grow and spread. It is used in combination with chemotherapy to treat ovarian cancer recurrence.^[11] Researchers are exploring combinations of bevacizumab with other new drugs to further improve outcomes.

These targeted drugs may be given with chemotherapy, on their own, or after chemotherapy has been completed, depending on the individual situation and treatment goals.^[7][13]

Radiation Therapy

While not a primary treatment for metastatic ovarian cancer, radiation therapy may occasionally be used. Radiotherapy employs high-energy rays to destroy cancer cells. It can be helpful for shrinking tumors and reducing symptoms, particularly when cancer has spread outside the abdomen. Doctors might use radiation to treat specific areas where cancer is causing problems or pain.^[13]

Innovative Treatments in Clinical Trials

Clinical trials represent the frontier of cancer treatment, offering access to promising new therapies before they become widely available. For patients with metastatic ovarian cancer, especially those whose disease has not responded well to standard treatments, clinical trials may provide additional options and hope.^[11]

Advanced Monoclonal Antibody Therapies

Researchers continue developing new monoclonal antibodies with different mechanisms of action. One recently approved drug called mirvetuximab soravtansine represents an innovative approach. This medication targets a protein called folate receptor alpha, which is found in high amounts on ovarian cancer cells but not on most normal cells. The drug functions like a guided missile, traveling through the body and attaching specifically to cells displaying this folate receptor. Once attached, it delivers chemotherapy directly to the cancer cell.^[11]

In patients whose ovarian cancer has recurred and whose tumors have many folate receptors, mirvetuximab soravtansine has shown remarkable results. The response rate is approximately double what is seen with other treatments, meaning about twice as many patients experience tumor shrinkage. This drug is used when cancer has been previously treated with at least one systemic therapy.^[11]

Understanding the Tumor Microenvironment

A significant area of research focuses on the tumor microenvironment, which refers to everything surrounding the tumor: immune cells, blood vessels, signaling molecules, and supportive tissues. Scientists have discovered that this environment plays a crucial role in helping cancer grow and spread. Various immune cells and signaling pathways, including TGF-β, NF-κB, and PI3K/AKT/mTOR, help cancer cells survive and thrive.^[8]

Researchers funded by organizations like the Ovarian Cancer Research Foundation are working on combination therapies that target these pathways. One promising approach involves blocking two proteins found in tumors, called G9a and EZH2. These proteins protect cancer cells from attacks by healthy immune cells. By using drugs to stop these proteins, researchers hope to reactivate immune cells so they can fight off cancer cells and prevent them from spreading. This work has progressed to the point of securing government research grants to continue developing combination drug therapies.^[4]

Immunotherapy Approaches

Immunotherapy treatments aim to harness the body’s own immune system to fight cancer. These therapies work by helping immune cells recognize and attack cancer cells more effectively. Various immunotherapy strategies are being tested in clinical trials for ovarian cancer, often in combination with other treatments to enhance their effectiveness.^[8]

Clinical Trial Phases and What They Mean

Clinical trials progress through several phases, each designed to answer specific questions about a new treatment. Phase I trials primarily test safety, determining what dose of a new drug can be given safely and identifying side effects. Phase II trials evaluate whether the treatment shows evidence of working against cancer, looking at outcomes like tumor shrinkage or symptom improvement. Phase III trials compare the new treatment directly with standard therapy to determine if it offers better results.^[11]

Patients participating in clinical trials contribute valuable information to medical science while potentially accessing treatments that may work better than existing options. Clinical trials are conducted at various locations, including major cancer centers in the United States, Europe, and other regions around the world. Eligibility requirements vary by study, taking into account factors like previous treatments, overall health status, and specific characteristics of the cancer.^[11]

Most Common Treatment Methods

• Surgery (Cytoreductive or Debulking Surgery)
  • Removal of both ovaries, fallopian tubes, uterus, and cervix
  • Removal of as much visible cancer as possible from the pelvis and abdomen
  • May include bowel resection, liver resection, removal of the omentum, and splenectomy in advanced cases
  • Can be performed after neoadjuvant chemotherapy (interval debulking surgery)
• Chemotherapy
  • Carboplatin plus paclitaxel as the standard first-line combination
  • Alternative chemotherapy drugs for recurrent disease
  • Hyperthermic intraperitoneal chemotherapy (HIPEC) during surgery in specialized centers
  • Can be given before surgery (neoadjuvant), after surgery (adjuvant), or both
• Targeted Therapy
  • PARP inhibitors (olaparib, niraparib, rucaparib) for maintenance therapy, especially in patients with BRCA mutations
  • Bevacizumab to prevent new blood vessel growth that feeds tumors
  • Mirvetuximab soravtansine targeting folate receptor alpha in recurrent disease
  • Can be used with chemotherapy, alone, or after chemotherapy
• Radiation Therapy
  • Used occasionally to shrink tumors and reduce symptoms
  • May be directed at specific areas where cancer is causing problems
  • Can provide pain relief and symptom control
• Immunotherapy (In Clinical Trials)
  • Treatments designed to help the immune system recognize and attack cancer cells
  • Combination therapies targeting proteins like G9a and EZH2 that protect cancer cells from immune attack
  • Various approaches being tested in Phase I, II, and III clinical trials
• Palliative and Supportive Care
  • Pain management with medications
  • Treatment for bowel obstructions
  • Drainage of fluid from the abdomen (ascites) or around the lungs
  • Nutritional support and management of nausea and vomiting
  • Interventions to maintain comfort and quality of life

Managing Symptoms and Maintaining Quality of Life

Even when a cure is not possible, treatments can often control metastatic ovarian cancer and relieve symptoms for many months and sometimes years. The focus shifts toward managing physical symptoms and maintaining the best possible quality of life.^[13][19]

Advanced cancer and its treatments can cause various physical symptoms that require careful management. These may include persistent pain, fatigue, constipation, nausea, shortness of breath, and complications like bowel obstruction. Healthcare teams work with patients to address these issues through pain medications, bowel regimens including daily stool softeners, anti-nausea drugs, and positioning adjustments. When fluid builds up in the abdomen (a condition called ascites) or around the lungs, procedures can drain this fluid to improve comfort and breathing.^[13][20]

Nutritional support becomes particularly important. Small, frequent meals and snacks throughout the day can help prevent nausea from worsening. Bland foods that are gentle on the stomach, such as clear broth, crackers, gelatin, ice pops, plain yogurt, and toast, may be easier to tolerate during chemotherapy. Dairy products, eggs, and nuts can provide extra calories and protein. After treatment, maintaining good nutrition with plenty of fruits and vegetables along with lean proteins supports overall health.^[23]

Exercise offers benefits even during cancer treatment, helping to offset anxiety, fatigue, and insomnia. Physical activity appropriate to the patient’s energy level and abilities can improve overall well-being.^[23]

Making Treatment Decisions and Planning Ahead

Only patients and their doctors can decide when to pursue further treatment, when to take a break, or when to stop active cancer treatment. This is a deeply personal decision that depends on many factors, including how the cancer is responding, what side effects are being experienced, and what matters most to the patient in terms of quality of life.^[20]

Many patients want to know about their outlook and how their cancer will develop. Doctors can provide estimates based on the stage of cancer, what treatments are available, how well treatments are working, and the patient’s general health and fitness level. For metastatic ovarian cancer, treatment can sometimes control the disease and relieve symptoms for many months or years, though outcomes vary widely among individuals.^[19]

Five-year relative survival rates provide one way to understand outcomes, though these are based on groups of patients and cannot predict any individual’s experience. For invasive epithelial ovarian cancer initially diagnosed at Stage IV, the 5-year relative survival rate is approximately 31 percent. For germ cell tumors and ovarian stromal tumors at Stage IV, the rates are higher, at 71 percent and 70 percent respectively. These rates continue to improve over time as better treatments become available.^[21]

Thinking about priorities and planning can help patients feel more in control. This might involve conversations about how to spend time, what remains important, and what practical matters need attention. Some people find it helpful to discuss memorial plans, caregiving arrangements, and legal matters like wills with their adult children or other loved ones. While these conversations are difficult, addressing them can bring peace of mind and ensure that wishes are respected.^[20]

For patients approaching end-stage cancer, hospice care provides comprehensive support focused on comfort and quality of life. Decisions about advance directives and preferences for care in different scenarios help guide the medical care received.^[20][21]

Emotional and Mental Health Support

The emotional impact of metastatic ovarian cancer can be overwhelming. Feelings may range from fear and confusion to grief and anger. These emotions are normal and expected responses to a serious diagnosis. Talking about these feelings and addressing concerns about body image, sexuality, and the future can provide significant relief.^[22]

Many patients benefit from connecting with others who understand what they are going through. Support groups, whether in person or online, provide spaces to share experiences, learn coping strategies, and feel less alone. Counselors and therapists with experience in cancer care can offer guidance through this challenging time. Healthcare providers can recommend appropriate support groups and mental health professionals.^[22]

Fear of recurrence is common, even after treatment has ended. This anxiety is a normal part of living with or beyond cancer. Professional counseling, support groups, and open communication with healthcare providers can help manage these concerns.^[16]

It is normal to experience a range of emotions that fluctuate over time. Some people view their situation as a time for peaceful reflection, while others feel disbelief, anger, or depression. There is no right or wrong way to feel. Acknowledging these emotions and seeking support when needed are important parts of coping.^[20]